elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34289698-E361F1CE-96D6-48E0-B84A-4CD99D929634
Q34289698-E361F1CE-96D6-48E0-B84A-4CD99D929634
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34289698-E361F1CE-96D6-48E0-B84A-4CD99D929634
IDO is a nodal pathogenic driver of lung cancer and metastasis development.
P2860
Q34289698-E361F1CE-96D6-48E0-B84A-4CD99D929634
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34289698-E361F1CE-96D6-48E0-B84A-4CD99D929634
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
18b496db6ae9f1014c33a3fedf056a5fe0953d1b
P2860
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan